About Glen Research
Glen Research is a Healthcare company based in Sterling (United States) founded in 1987, and was acquired by Maravai Life Sciences in January 2018. Research Reagents for DNA research. Its website glenresearch.com draws about 24 thousand monthly visits. Glen Research offers products and services including Natural DNA Phosphoramidites, Natural RNA Phosphoramidites, Glen-Pak Purification Products, and Ancillary Reagents. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Kits and Reagents. Its competitors include GenScript, RareCyte and Sequenta; 3 of its 3 listed competitors have raised funding.
Company details
Glen Research offers a wide range research reagents in DNA research. The product portfolio of the company includes RNA Synthesis and DNA Synthesis Reagents Phosphoramidites, Monomers and Supports for Synthesis of Modified, Labelled Oligonucleotides, ZNA, ZIP and several other reagents. They also have minor bases, labelling, and modification reagents.
- Headquarters Sterling, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website glenresearch.com
- Social LinkedIn Facebook
- Acquired by Maravai Life Sciences (Jan 2018)
- Investors
- Acquired byMaravai Life Sciences
(Jan 2018)
Products & Services of Glen Research
Glen Research offers a comprehensive portfolio of products and services, including Natural DNA Phosphoramidites, Natural RNA Phosphoramidites, Glen-Pak Purification Products, and Ancillary Reagents.
Reagents for synthesizing DNA oligonucleotides in research applications.
Supports RNA oligonucleotide production for molecular studies.
Tools for purifying oligonucleotides via reverse phase methods.
Chemicals aiding in capping and oxidation during synthesis processes.
Investors in Glen Research
Glen Research has secured backing from 1 investor. Prominent investors backing the company include Maravai Life Sciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provides enabling tools and services in the life sciences research and bio-production industries | 2014 | maravai.com | San Diego, United States |
Investor details for Glen Research
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Glen Research
2 dated milestones of Glen Research across 31 years, from founding to its latest funding, stage changes and deals.
- Founded Glen Research is founded.
- Exit Acquired by Maravai Life Sciences.
Competitors of Glen Research
Glen Research has 3 listed competitors in our database, 3 of them funded. They include GenScript, RareCyte and Sequenta.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| rarecyte.com | 2009 | Seattle, United States | $114.33M | 54 | Developer of technologies for the analysis of rare and single cells in the blood | |
| sequenta.com | 2008 | San Francisco, United States | $43.46M | 58 | Immuno-sequencing products are developed for disease diagnostics and treatment. |
Detailed competitors of Glen Research
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Glen Research
The website of Glen Research (glenresearch.com) receives about 23.7K visits a month.
- Monthly visits23.7K
▲ 2.9% vs previous month
Websites whose visitors overlap most with Glen Research. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| genelink.com | 100% | 10.8K | #2,265,843 | View details | |
| iris-biotech.de | 92% | #907,704 | View details | ||
| chemgenes.com | 86% | #2,747,774 | View details | ||
applichem.com | applichem.com | 77% | – | ||
| biotage.com | 77% | 39.5K | #741,731 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 34 similar websites and full traffic analytics for Glen Research
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 34 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Glen Research (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Glen Research
Complete news archive for Glen Research
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Glen Research
Glen Research was founded in 1987.
Glen Research is headquartered in Sterling, United States.
Glen Research offers a wide range research reagents in DNA research. The product portfolio of the company includes RNA Synthesis and DNA Synthesis Reagents Phosphoramidites, Monomers and Supports for Synthesis of Modified, Labelled Oligonucleotides, ZNA, ZIP and several other reagents. They also have minor bases, labelling, and modification reagents.
Glen Research offers Natural DNA Phosphoramidites, Natural RNA Phosphoramidites, Glen-Pak Purification Products, and Ancillary Reagents.
Glen Research has 1 investor. Key investors include Maravai Life Sciences.
Yes. Glen Research was acquired by Maravai Life Sciences in January 2018.